Cencora Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Cencora Inc.
- Former names
- Amerisourcebergen Corp Amerisource Bergen Corp
- Ownership
- Public
- Status
- Active
- SIC code
- 5122 — Wholesale-Drugs, Proprietaries & Druggists' Sundries
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Conshohocken
- Headquarters state / province
- Pennsylvania
- Headquarters country
- United States
- Fiscal year end
- September
- Ticker symbol
- COR
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0001140859
- EIN
- 23-3079390
Board of directors
-
Dennis M. Nally · DirectorSince 2023
-
Dermot Mark Durcan · DirectorSince 2023
-
Ellen Cooper · DirectorSince 2026
-
Frank Clyburn · DirectorSince 2024
-
Henry Wadsworth McGee III · DirectorSince 2023
-
Jane E. Henney M.D. · DirectorSince 2023
-
Kathleen W. Hyle · DirectorSince 2023
-
Lauren M. Tyler · DirectorSince 2023
-
Lon R. Greenberg · DirectorSince 2023
-
Lorence H. Kim · DirectorSince 2023
-
Lori Ryerkerk · DirectorSince 2025
-
Michael J. Long · DirectorSince 2023
-
Redonda Miller · DirectorSince 2023
-
Richard W. Gochnauer · DirectorSince 2023
-
Robert P. Mauch · Director · President & CEOSince 2024
-
Steven H. Collis · Director · Executive ChairmanSince 2023
-
Werner Baumann · DirectorSince 2023
Chief executives
Steven H. Collis
· Chairman, President & CEO
Dates unknown
Robert P. Mauch
· President & CEO
Dates unknown
Director election results
Annual meeting of March 5, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
96.9%
-
98.5%
-
98.5%
-
98.9%
-
99.1%
-
99.1%
-
99.3%
-
99.9%
-
99.9%
-
99.9%
-
100.0%
Board connections
10 of this board's directors also sit on 14 other boards.
- via Frank Clyburn and Lorence H. Kim
- via Dermot Mark Durcan
- via Michael J. Long
- via Steven H. Collis
- via Lori Ryerkerk
- via Lauren M. Tyler
- via Lori Ryerkerk
- via Steven H. Collis
- via Frank Clyburn
- via Ellen Cooper
- via Michael J. Long
- via Dennis M. Nally
- via Lori Ryerkerk
- via Kathleen W. Hyle
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $2,310,427
- 3 purchases by 2 insiders
- Sold, last 12 months
- $17,015,911
- 13 sales by 5 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 16, 2026 | Lon R. Greenberg Director | Open-market sale | −1,280 | $321.30 | $411,264 |
| Sep 1, 2026 | Krikorian Lazarus Officer (SVP & Chief Accounting Officer) | Open-market sale | −985 | $325.97 | $321,080 |
| Aug 24, 2026 | Campbell Elizabeth S Officer (Executive Vice President) | Open-market sale | −11,300 | $324.12 | $3,662,663 |
| Jul 31, 2026 | Ellen Cooper Director | Grant or award | +97 | $311.34 | $30,200 |
| Jul 31, 2026 | Dennis M. Nally Director | Grant or award | +113 | $311.34 | $35,181 |
| Jul 31, 2026 | Lauren M. Tyler Director | Grant or award | +97 | $311.34 | $30,200 |
| Jun 30, 2026 | Silvana Battaglia Officer (Executive Vice President) | Grant or award | +58 | $240.53 | $14,000 |
| Jun 30, 2026 | Campbell Elizabeth S Officer (Executive Vice President) | Grant or award | +50 | $240.53 | $12,000 |
| Jun 22, 2026 | Lauren M. Tyler Director | Open-market purchase | +550 | $270.23 | $148,627 |
| Jun 18, 2026 | Dermot Mark Durcan Director | Open-market purchase | +4,000 | $274.19 | $1,096,760 |
| May 28, 2026 | Dermot Mark Durcan Director | Open-market purchase | +4,000 | $266.26 | $1,065,040 |
| May 1, 2026 | Lauren M. Tyler Director | Grant or award | +99 | $304.00 | $30,096 |
| May 1, 2026 | Ellen Cooper Director | Grant or award | +99 | $304.00 | $30,096 |
| May 1, 2026 | Dennis M. Nally Director | Grant or award | +116 | $304.00 | $35,264 |
| Mar 11, 2026 | Silvana Battaglia Officer (Executive Vice President) | Option exercise | +8,415 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.